01 ARIPIPRAZOLE LAUROXIL (4)
01 ALKERMES INC (4)
01 SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (4)
01 1064MG/3.9ML (272.82MG/ML) (1)
02 441MG/1.6ML (275.63MG/ML) (1)
03 662MG/2.4ML (275.83MG/ML) (1)
04 882MG/3.2ML (275.63MG/ML) (1)
01 USA (4)
19
Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .
proudly manufactured in the
approval since 2015-10-05
Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 882MG/3.2ML (275.63MG/ML) of ARIPIPRAZOLE LAUROXIL.
18
Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .
proudly manufactured in the
approval since 2015-10-05
Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 441MG/1.6ML (275.63MG/ML) of ARIPIPRAZOLE LAUROXIL.
17
Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .
proudly manufactured in the
approval since 2017-06-05
Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 1064MG/3.9ML (272.82MG/ML) of ARIPIPRAZOLE LAUROXIL.
16
Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .
proudly manufactured in the
approval since 2015-10-05
Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 662MG/2.4ML (275.83MG/ML) of ARIPIPRAZOLE LAUROXIL.